Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Louis Talay, Matt Vickers
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Diabetes, Obesity and Metabolism
Online Access:https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15607
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View
Description
DOI:10.1111/dom.15607

Similar Items

  • Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study
    by: Yu‐Nan Huang, et al.
    Published: (2024)
  • Trends in obesity and glucagon‐like peptide‐1 receptor agonist prescriptions in type 1 diabetes in the United States
    by: Yunwen Xu, et al.
    Published: (2025)
  • Treating class 2–3 obesity with glucagon‐like peptide‐1 agonists: A 2‐year real‐world cohort study
    by: Mona Abdel‐Bary, et al.
    Published: (2025)
  • Correction to “Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study”
    Published: (2025)
  • Risks of peri‐ and postoperative complications with glucagon‐like peptide‐1 receptor agonists
    by: David C. Klonoff, et al.
    Published: (2024)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs